Table 2.

Comparison of Glycemic Outcomes for Users Who Had ≥75% Continuous Glucose Monitoring Use (Baseline vs. 12-Month Use of Control-IQ)

	Baseline (Basal-IQ)	12-mth control-IQ use	P
All users
No. of participants	9010	9010
Mean sensor glucose [mg/dL]	164 (146–185)	152 (140–166)	<0.001
Sensor time <54 mg/dL [%]	0.10 (0.00–0.30)	0.15 (0.06–0.30)	<0.001
Sensor time 54–70 mg/dL [%]	0.8 (0.3–1.8)	0.9 (0.4–1.6)	0.053
Sensor TIR [%]	63.6 (50.0–75.7)	73.6 (64.5–81.8)	<0.001
Sensor time 180–250 mg/dL [%]	25.1 (18.0–31.1)	19.7 (14.2–24.3)	<0.001
Sensor time >250 mg/dL [%]	8.1 (2.9–16.7)	4.6 (1.9–9.5)	<0.001
Coefficient of variation [%]	33.7 (30.0–37.6)	32.9 (29.5–36.3)	<0.001
GMI	7.2 (6.8–7.7)	6.9 (5.6–7.3)	<0.001
T1DM users
No. of participants	7813	7813
Mean sensor glucose [mg/dL]	163 (141–190)	151 (134–170)	<0.001
Sensor time <54 mg/dL [%]	0.01 (0.00–0.35)	0.02 (0.00–0.4)	<0.001
Sensor time 54–70 mg/dL [%]	0.9 (0.3–1.9)	0.9 (0.5–1.7)	0.123
Sensor TIR [%]	63.2 (49.8–75.1)	73.5 (64.4–81.6)	<0.001
Sensor time 180–250 mg/dL [%]	25.2 (18.2–31.0)	19.7 (14.3–24.2)	<0.001
Sensor time >250 mg/dL [%]	8.3 (3.1–16.9)	4.7 (2.0–9.6)	<0.001
T2DM users
No. of participants	378	378
Mean sensor glucose [mg/dL]	158 (138–184)	150 (136–169)	<0.001
Sensor time <54 mg/dL [%]	0.00 (0.0–0.07)	0.04 (0.01–0.10)	<0.001
Sensor time 54–70 mg/dL [%]	0.2 (0.0–0.6)	0.2 (0.0–0.6)	0.337
Sensor TIR [%]	69.9% (55.1–82.6)	78.0% (66.2–86.1)	<0.001
Sensor time 180–250 mg/dL [%]	23.9 (14.6–32.0)	19.0 (12.4–25.5)	<0.001
Sensor time >250 mg/dL [%]	3.6 (0.7–10.4)	2.3 (0.8–6.7)	<0.001

Data are expressed as median (IQR) unless otherwise specified.

GMI, glucose management indicator; IQR, interquartile range; T1DM, type 1 diabetes; T2DM, type 2 diabetes; TIR, time in range.